Non-invasive and Invasive Plaque Characterisation

Sponsor
University Medical Center Groningen (Other)
Overall Status
Terminated
CT.gov ID
NCT01833338
Collaborator
(none)
30
1
1
23
1.3

Study Details

Study Description

Brief Summary

The accuracy of coronary plaque characterization with Multi-slice computed tomography as compared to intravascular ultrasound and optical coherence tomography will be investigated in patients presenting with acute coronary syndrome without ST-elevation.

Condition or Disease Intervention/Treatment Phase
  • Device: Imaging
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Coronary Artery Plaque Characterisation With Non-invasive Multi-Slice Computed Tomography and Invasive Intravascular Ultrasound and Optical Coherence Tomography in Patients With Acute Coronary Syndromes Without ST-segment Elevation
Study Start Date :
Jun 1, 2011
Actual Primary Completion Date :
May 1, 2013
Actual Study Completion Date :
May 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Other: Single arm

There is only one arm in this study. All patients undergo MSCT, IVUS and OCT.

Device: Imaging
All patients undergo non-invasive (MSCT) and invasive (IVUS, OCT) imaging
Other Names:
  • OCT: C7-XR™ OCT Intravascular Imaging System, St.Jude Medical
  • IVUS: Galaxy 2 IVUS Imaging System, Boston Scientific
  • MSCT: Dual-source CT scanner Somatom Definition, Siemens Healhtcare
  • Outcome Measures

    Primary Outcome Measures

    1. Accuracy of detection of thrombus with MSCT as compared to IVUS and OCT will be investigated. [24 hours]

      All imaging methods will be performed in each patient. A 24 hour period is the maximum allowed time gap between MSCT and invasive imaging (OCT/IVUS).

    Secondary Outcome Measures

    1. Accuracy of atherosclerotic plaque characterisation with MSCT as compared to IVUS and OCT will be investigated. [24 hours]

      A maximum interval of 24 hours between MSCT and IVUS/OCT is allowed in this study.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Chest pain suggestive for myocardial ischemia for at least 30 minutes; - Electrocardiogram (ECG) with ST-segment shifts (ST-segment depression >1 mm in at least two contiguous leads or transient ST-segment elevation > 1mm with duration of < 30 min in at least two contiguous leads) and/or T-wave changes (T-wave inversion > 1.5 mm in at least three contiguous leads); - Positive hs Troponin T > 14 ng/L or positive Troponin T <0.01 µg/L - Clinical indication for invasive coronary angiography followed by PCI of the ischemia-related target lesion; - Informed consent.
    Exclusion Criteria:
    • Persistent ST-elevation of >1 mm in 2 or more leads; - Need for emergency invasive coronary angiography and percutaneous coronary intervention (PCI); - Need for emergency coronary artery bypass grafting; - Presence of cardiogenic shock; - Estimated glomerular filtration rate (eGFR) < 50 ml/min; - Known allergy to iodine contrast agents; - Cardiac rhythms other than sinus rhythm; - Inability to lay supine;
    • Inability tot sustain a breath-hold for 15 seconds; - Inability to provide informed consent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Medical Center Groningen, Departments of Cardiology and Radiology Groningen Netherlands 9700 RB

    Sponsors and Collaborators

    • University Medical Center Groningen

    Investigators

    • Principal Investigator: Gabija Pundziute, MD, PhD, Department of Cardiology
    • Principal Investigator: Tineke Willems, MD, PhD, Department of Radiology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Gabija Pundziute, Principal Investigator, University Medical Center Groningen
    ClinicalTrials.gov Identifier:
    NCT01833338
    Other Study ID Numbers:
    • METcUMCG 2010.266
    First Posted:
    Apr 16, 2013
    Last Update Posted:
    Sep 11, 2014
    Last Verified:
    Sep 1, 2014
    Keywords provided by Gabija Pundziute, Principal Investigator, University Medical Center Groningen
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 11, 2014